Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PinnacleXon Aug 30, 2019 3:58pm
135 Views
Post# 30084616

RE:Hard pressed comment by Luc just over a month ago

RE:Hard pressed comment by Luc just over a month ago
palinc2000 wrote: I think anyone would be hard-pressed not to be excited about the future of Trogarzo. Already, it's having a profound impact on our company, but we are more than ever convinced that it will be the game changer that we thought it would be for Theratechnologies in due course based on the fact that we have made and keep making the right moves.l 

I must be hard pressed because I am not excited!!!
I also think that Luc is one of a very few who is excited


You re not the only one over hyped mediocre drug that doesn't sell well, guess the excuse now it's a slow month therefore the low sales, what they got 8 new patients is that a joke? But I'm sure we were hear the same old posts on what awesome catalysts are coming like we have for oh 1.5 years now. You put a multiple on this and it's still way over priced when you look at the financials it did look great years ago now reality set in and we can see the bullshit and over promises, biggest pharma in Canada it will never be hey luc boy
Bullboard Posts